ubenimex has been researched along with Malignant Melanoma in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Arrebola, Y; Bergado, G; Charli, JL; Díaz-Guevara, L; Méndez, LR; Pascual Alonso, I; Sánchez, B; Valdés-Tresanco, ME | 1 |
| Aozuka, Y; Koizumi, K; Saiki, I; Saitoh, Y; Sakurai, H; Ueda, Y | 1 |
| Mathe, G | 1 |
| Hayasaka, K; Ikeda, S; Ishihara, K; Jimbow, K; Kukita, A; Seki, Y; Takahashi, H; Terakado, T | 1 |
| Hayasaka, K; Ishihara, K; Yamazaki, N | 1 |
| Ikeda, S; Ishihara, K; Taguchi, G | 1 |
| Esumi, H; Ikeda, S; Suzuki, T; Tomita, Y | 1 |
1 review(s) available for ubenimex and Malignant Melanoma
| Article | Year |
|---|---|
Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Topics: Adjuvants, Immunologic; Animals; Aziridines; BCG Vaccine; Breast Neoplasms; Cyclophosphamide; Dose-Response Relationship, Immunologic; Humans; Immunotherapy; Leucine; Leukemia L1210; Leukemia, Lymphoid; Levamisole; Lymphoma, Non-Hodgkin; Melanoma; Methotrexate; Mice; Neoplasms; Propionibacterium acnes; T-Lymphocytes, Regulatory; Thymosin | 1980 |
2 trial(s) available for ubenimex and Malignant Melanoma
| Article | Year |
|---|---|
[Phase III study of bestatin in patients with malignant skin tumors. (1) Malignant melanoma].
Topics: Adult; Aged; Antibiotics, Antineoplastic; Clinical Trials as Topic; Drug Administration Schedule; Female; Humans; Leucine; Lymph Node Excision; Male; Melanoma; Middle Aged; Prognosis; Skin Neoplasms | 1985 |
[Multidisciplinary treatment of malignant melanoma].
Topics: Adult; Aged; Female; Humans; Leucine; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Staging; Picibanil; Prognosis; Sex Factors; Skin Neoplasms | 1985 |
4 other study(ies) available for ubenimex and Malignant Melanoma
| Article | Year |
|---|---|
Bestatin and bacitracin inhibit porcine kidney cortex dipeptidyl peptidase IV activity and reduce human melanoma MeWo cell viability.
Topics: Animals; Antineoplastic Agents; Bacitracin; Cell Line, Tumor; Cell Membrane; Cell Survival; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kidney; Leucine; Melanoma; Models, Molecular; Structure-Activity Relationship; Swine | 2020 |
Anti-tumor angiogenesis effect of aminopeptidase inhibitor bestatin against B16-BL6 melanoma cells orthotopically implanted into syngeneic mice.
Topics: Animals; Endothelial Cells; Female; Leucine; Melanoma; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Neovascularization, Pathologic; Protease Inhibitors; Skin Neoplasms; Transplantation, Heterologous; Umbilical Veins | 2004 |
[Malignant melanoma in Japan: unique distribution and effect of DAV chemoimmunotherapy].
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Therapy, Combination; Female; Humans; Leucine; Male; Melanoma; Middle Aged; Nimustine; Nitrosourea Compounds; Picibanil; Proteoglycans; Skin Neoplasms; Vincristine | 1982 |
Current status of melanoma treatment with interferon, cytokines and other biologic response modifiers in Japan.
Topics: Biological Factors; Biological Products; Cell Wall Skeleton; Cytokines; DNA, Bacterial; Glycine; Humans; Interferon Type I; Interferon-gamma; Interferons; Interleukin-2; Leucine; Male; Melanoma; Middle Aged; Mucoproteins; Mycolic Acids; Picibanil; Recombinant Proteins; Skin Neoplasms; Tumor Necrosis Factor-alpha | 1989 |